Holland & Knight Advises Global Nephrology Solutions in Investment Deal with Audax Private Equity
MIAMI (January 14, 2021) – Holland & Knight represented Global Nephrology Solutions (GNS), one of the nation's leading physician-led nephrology organizations, in connection with its strategic investment from Audax Private Equity (Audax). The transaction was announced on Jan. 13.
Headquartered in Tempe, Arizona, GNS has more than 300 providers and 500 employees and supports physicians who provide care across 10 states. The organization is focused on the quadruple aim of improving outcomes, reducing the cost of care, and enhancing both the patient and physician experience. GNS is transforming the kidney care space by leveraging next-generation data analytics, vast industry knowledge and experience, and cost-effective population health initiatives.
Audax Private Equity is a leading middle market private equity firm with offices in Boston and San Francisco. The firm has invested over $6 billion in more than 135 platform companies.
Holland & Knight Partners David Barkus, Tammy Knight, Jordan Taylor and Melissa Wong led the firm's representation of GNS. GNS was also advised by Marc Cabrera, co-head of healthcare, and Jason Friedman, director, of Oppenheimer & Co. Inc.
More information about the transaction can be found here.